A new study published in the scientific journal PLOS Pathogens points out that mice lacking a protein called Tmprss2 are no longer affected by certain flu viruses.
Influenza virus, magnified by electron microscopy. © HZI / Rohde
The discovery was made by researchers from the Helmholtz Centre for Infection Research (HZI) in Braunschweig in collaboration with colleagues from Göttingen and Seattle.
Whether it is H1N1, H5N1 or H7N9: The flu virus influenza A exists in many different types as its two coating proteins haemagglutinin (HA) and neuraminidase (NA) can be combined in various ways. Theoretically, more than 100 different pairings are possible. Additionally, the coating proteins themselves can undergo changes. This variability is one of the reasons why the flu vaccination has to be renewed every year.
The virus uses haemagglutinin as a key to enter the host cell which is then captured to build new virus particles. To reach its final shape, the coating protein has to be cleaved by a molecular scissor. This is done by an enzyme of the infected host. Otherwise, the protein is not functional and the virus particles are not infectious. A variety of host enzymes, so-called proteases, that process the haemagglutinin have been identified using cell cultures.
Scientists from the HZI have now been able to show how important those enzymes are for the progression of the infection. Mice with a mutation in the gene for the protease Tmprss2 do not become infected by flu viruses containing haemagglutinin type H1. They are resistant against H1N1, the pathogen responsible for seasonal influenza epidemics, the “swine flu” and the “Spanish flu”, which caused an epidemic in 1918. “These mice do not lose weight and their lungs are almost not impacted,” says Professor Klaus Schughart, head of the Department “Infection Genetics” at the HZI. “Even though the virus still multiplies no active viral particles are formed which would infect the neighbouring cells.” The infection is quickly terminated.
As the protease Tmprss2 is a host factor it is an ideal intervention point for new drugs. So far, treatments, such as the well-known Tamiflu, attack parts of the virus. They have decisive disadvantages: The virus can become resistant and the therapy no longer takes effect. This problem does not occur when the medication intervenes with the metabolism of the patient. Furthermore, the mice Schughart and his team examined did not show any abnormalities. “We did not observe an obvious varied phenotype in these mice. They were neither impaired in their behaviour nor in their life expectancy. Presumably because other proteins are compensating for the lack of Tmprss2,” says Dr Bastian Hatesuer, one of the scientists involved in the project. Blocking TMPRSS2 for a short period could be a new therapeutic option as no strong side effects are expected.
Even though a drug like this is still a long way off, the observation is important for another reason: “Until now the dependence of virus production on proteases had only be demonstrated in cell cultures,” says Schughart. “We are the first to show this in a living organism.”
It is likely that there are humans having the same defect as the mice and who therefore may be resistant against specific flu viruses. This, however, remains unnoticed. “Because they don’t get sick, they don’t go to see a doctor,” says Hatesuer. “Thus, they don’t know that they are resistant.”Original publication:
- This release on helmholtz-hzi.dehttp://www.plospathogens.org/article/info%3Adoi%2F10.1371%2Fjournal.ppat.1003774
Dr. Jan Grabowski | Helmholtz-Zentrum
Scientists unlock ability to generate new sensory hair cells
22.02.2017 | Brigham and Women's Hospital
New insights into the information processing of motor neurons
22.02.2017 | Max Planck Florida Institute for Neuroscience
In the field of nanoscience, an international team of physicists with participants from Konstanz has achieved a breakthrough in understanding heat transport
Cells need to repair damaged DNA in our genes to prevent the development of cancer and other diseases. Our cells therefore activate and send “repair-proteins”...
The Fraunhofer IWS Dresden and Technische Universität Dresden inaugurated their jointly operated Center for Additive Manufacturing Dresden (AMCD) with a festive ceremony on February 7, 2017. Scientists from various disciplines perform research on materials, additive manufacturing processes and innovative technologies, which build up components in a layer by layer process. This technology opens up new horizons for component design and combinations of functions. For example during fabrication, electrical conductors and sensors are already able to be additively manufactured into components. They provide information about stress conditions of a product during operation.
The 3D-printing technology, or additive manufacturing as it is often called, has long made the step out of scientific research laboratories into industrial...
Nature does amazing things with limited design materials. Grass, for example, can support its own weight, resist strong wind loads, and recover after being...
Nanometer-scale magnetic perforated grids could create new possibilities for computing. Together with international colleagues, scientists from the Helmholtz Zentrum Dresden-Rossendorf (HZDR) have shown how a cobalt grid can be reliably programmed at room temperature. In addition they discovered that for every hole ("antidot") three magnetic states can be configured. The results have been published in the journal "Scientific Reports".
Physicist Dr. Rantej Bali from the HZDR, together with scientists from Singapore and Australia, designed a special grid structure in a thin layer of cobalt in...
13.02.2017 | Event News
10.02.2017 | Event News
09.02.2017 | Event News
22.02.2017 | Power and Electrical Engineering
22.02.2017 | Life Sciences
22.02.2017 | Physics and Astronomy